公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 BIOSYS LTDA取消

83 记录

产品持有公司班级有效性
BENZODIAZEPÍNICOS E ANTIDEPRESSIVOS TRICÍCLICOS10350840116BIOSYS LTDAIII16/11/2036
DROGAS ANTI EPILETICAS NO SORO OU PLASMA (HPLC)10350840118BIOSYS LTDAIII26/10/2036
Metanephrines in Urine HPLC10350840132BIOSYS LTDAIII13/07/2036
MasCheck Amino acids, acylcarnitines incl. succinylacetone dried blood spot control, bi-Level (I+II)10350840187BIOSYS LTDAIII23/06/2035
Immunosuppressants Whole Blood Control, Four- Level (I+II+III+IV)10350840239BIOSYS LTDAIII30/12/2033
MassTox Immunosuppressants in whole blood10350840243BIOSYS LTDAIII31/03/2034
6plus1 Multilevel Calibrator Set Immunosuppressants in Whole Blood10350840244BIOSYS LTDAIII31/03/2034
Família de Controles - Endocrine Control10350840252BIOSYS LTDAIII24/11/2035
MassChrom Amino acids and acylcarnitines from dried blood10350840260BIOSYS LTDAIII22/12/2034
Tricyclic Antidepressants plasma controls Bi-Level (I+II)10350840262BIOSYS LTDAIII24/11/2035
MassChrom Amino acids and acylcarnitines from dried blood - Derivatised10350840263BIOSYS LTDAIII02/02/2035
Família de Controles Plasma Endocrine Control10350840271BIOSYS LTDAIII16/03/2036
ichroma CK-MB Neo10350840277BIOSYS LTDAIII14/12/2035
i-CHROMA Tn-I Neo10350840278BIOSYS LTDAIII21/12/2035
ichroma D-Dimer Neo10350840279BIOSYS LTDAIII28/12/2035
ichroma PSA Neo10350840281BIOSYS LTDAIII18/01/2036
FAMÍLIA ichroma PCT10350840283BIOSYS LTDAIII02/03/2036
ichroma Myoglobin Neo10350840287BIOSYS LTDAIII06/10/2035
ichroma NT-proBNP10350840315BIOSYS LTDAIII06/10/2035
Metanephrines Urine Calibration Standard10350840336BIOSYS LTDAIII13/04/2036
Família Boditech Cardiac10350840338BIOSYS LTDAIII15/10/2028
AFIAS CK-MB Neo10350840339BIOSYS LTDAIII22/10/2028
FAMÍLIA IMMUNOSUPPRESSANTS IN WHOLE BLOOD ONE MINUTE TEST - AUTO10350840343BIOSYS LTDAIII03/12/2028
Família AFIAS D-Dimer10350840345BIOSYS LTDAIII18/02/2029
Família Tn-I Plus10350840347BIOSYS LTDAIII25/03/2029

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家